ReacX Pharmaceuticals
Company Details
Status: Private
Employees: 1-10
Location:
South San Francisco, California, United States
Type:
sample
sample
Technology:
sample
sample
About: ReacX Pharmaceuticals, Inc., headquartered in South San Francisco, CA, is a commercial-stage biopharmaceutical company developing therapeutics based on its proprietary ProNeura™ drug delivery technology. The company’s flagship product, Probuphine®, is the first FDA-approved long-acting formulation of buprenorphine designed for the maintenance treatment of opioid dependence. It provides continuous, six-month drug delivery following a single implant procedure, ensuring consistent therapeutic levels.
Beyond opioid addiction treatment, ProNeura™ technology is being explored as a platform to develop treatments for other chronic conditions such as diabetes, psychosis, multiple sclerosis, and even weight loss where stable, long-term drug release can enhance patient care and outcomes.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ReacX Pharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.